Share on LinkedInShare on LinkedIn

ARTICLE · 12 MARCH 2010

Supreme Court Docket Report - March 8, 2010

Mayer Brown
Mayer Brown
Contributor
Mayer Brown

Mayer Brown

Mayer Brown is a leading international law firm positioned to represent the world’s major...

View firm profile
Explore more from Mayer Brown

The National Childhood Vaccine Injury Act of 1986 ("Vaccine Act") , 42 U.S.C. §§ 300aa-1 et seq., expressly preempts state-law claims against vaccine manufacturers if the injury or death giving rise to such a claim "resulted from side effects that were unavoidable even though the vaccine was properly prepared and was accompanied by proper directions and warning."

United StatesLitigation, Mediation & Arbitration

Originally published March 8, 2010

Keywords: federal preemption, state law claims, National Childhood Vaccine Injury Act, Vaccine Act, Chase Bank, Providence, Moses

Today the Supreme Court granted certiorari in one case of interest to the business community:

Federal Preemption of State-Law Claims—National Childhood Vaccine Injury Act

The National Childhood Vaccine Injury Act of 1986 ("Vaccine Act") , 42 U.S.C. §§ 300aa-1 et seq., expressly preempts state-law claims against vaccine manufacturers if the injury or death giving rise to such a claim "resulted from side effects that were unavoidable even though the vaccine was properly prepared and was accompanied by proper directions and warning." 42 U.S.C. § 300aa-22(b)(1). The lower courts are divided over the scope of that provision. Today, the Supreme Court granted certiorari in Bruesewitz v. Wyeth, No. 09-152, to decide whether the Vaccine Act categorically preempts all design-defect claims against vaccine

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from